Virbac stock trades at EUR 302 after 7.4 percent H1 growth

Virbac stock stood at EUR 302 on Euronext Paris on September 24, 2026, down 0.82 percent from the prior session. The French animal health company delivered H1 2026 revenue of EUR 768.0 million, up 7.4 percent at constant exchange rates and scope.

Revenue growth stays broad

Virbac's first-half performance covered both main business lines. Companion animal revenue rose 10.0 percent, while farm animal revenue increased 6.7 percent in H1 2026, according to Reuters on September 17, 2026.

The comparison is meaningful because reported revenue rose 4.0 percent at actual exchange rates from EUR 738.3 million in H1 2025 to EUR 768.0 million in H1 2026. The 7.4 percent constant-rate increase shows that currency effects reduced the reported growth rate by 3.4 percentage points.

Margin widens by 0.5 points

Adjusted EBIT before amortizations reached EUR 144.2 million in H1 2026, compared with EUR 135.0 million in H1 2025. That represents a 6.8 percent increase, while the adjusted EBIT margin rose from 18.3 percent to 18.8 percent, according to GlobeNewswire in the September 17, 2026 release.

The margin improvement matters because Virbac is funding growth platforms while expanding its product base. Consolidated net income also increased 5.9 percent to EUR 87.1 million from EUR 82.2 million in the prior-year period, giving the operating improvement a corresponding earnings effect.

Guidance points to the upper end

Virbac confirmed its 2026 revenue growth guidance range of 5.5 percent to 7.5 percent at constant exchange rates and scope. Reuters reported on September 17, 2026 that management was targeting the upper end after the first-half growth rate reached 7.4 percent.

The market response remains more cautious than the operating figures. Virbac stock was EUR 302 on September 24, 2026, versus a 52-week high of EUR 389.50 and a 52-week low of EUR 297, placing the share 22.46 percent below the yearly high and EUR 5 above the low.

Stock stays near yearly low

Virbac's market capitalization was EUR 2,530,102,848 on September 24, 2026. The combination of a 0.82 percent daily decline and a price near the EUR 297 yearly low indicates that investors are weighing the strong first-half figures against the company's investment and currency profile.